)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Karolinska Development
Karolinska Development (KDEV) investor relations material
Karolinska Development Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary30 Apr, 2026
Executive summary
Net loss for Q1 2026 was SEK -34.1 million, widening from SEK -14.2 million in Q1 2025, mainly due to negative fair value changes in portfolio holdings and earn-out agreements.
Rights issue raised SEK 115.2 million before costs, strengthening liquidity and broadening the shareholder base.
Portfolio companies advanced clinical programs, with Dilafor signing a major licensing deal and AnaCardio securing a key US patent.
Financial highlights
Net sales were SEK 0.4 million in Q1 2026, down from SEK 0.5 million in Q1 2025.
Change in fair value of shares in portfolio companies was SEK -11.6 million (Q1 2025: SEK -3.5 million).
Change in fair value of other financial assets and liabilities (earn-outs) was SEK -18.0 million (Q1 2025: SEK -6.1 million), due to the write-down of the Forendo Pharma earn-out.
Net asset value at March 31, 2026 was SEK 1,105.5 million (SEK 1.7 per share), up from SEK 1,044.7 million (SEK 3.9 per share) a year earlier, with the per-share decrease due to share issuance.
Cash and cash equivalents increased to SEK 106.3 million (Q1 2025: SEK 51.1 million).
Investments in portfolio companies totaled SEK 8.0 million (Q1 2025: SEK 15.5 million).
Outlook and guidance
Several portfolio companies are approaching key clinical milestones and potential licensing deals in 2026–2027.
Management expects continued value inflection from clinical data and business development activities.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Karolinska Development
- Net loss widened in 2025, but a SEK 115m rights issue and clinical progress support future growth.KDEV
Q4 202513 Feb 2026 - Q3 2025 saw a sharp net loss and portfolio value drop, but clinical progress continued.KDEVQ3 202514 Nov 2025
- Q2 2025 saw a sharp net loss and portfolio value drop, offset by improved liquidity from divestments.KDEVQ2 202529 Aug 2025
- Portfolio value rose despite a net loss, with key clinical and investment milestones achieved.KDEVQ3 202413 Jun 2025
- Q2 2024 saw a net loss, stable portfolio value, and major clinical and investment milestones.KDEVQ2 202413 Jun 2025
- Q1 2025 saw a net loss and lower portfolio value, but strong clinical and financing milestones.KDEVQ1 20255 Jun 2025
- 2024 saw a net loss but strong Q4 profit, major portfolio progress, and improved liquidity.KDEVQ4 20245 Jun 2025
Next Karolinska Development earnings date
Q2 202628 Aug, 2026
Karolinska Development
Next Karolinska Development earnings date
Q2 202628 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage